Pharmintech, the international exhibition for technology, materials and services for the processing and packaging of pharmaceutical, personal care and nutraceutical products is scheduled to take place at BolognaFiere from May 12 to 14 2010.
The Indian Drug Manufacturers Association Gujarat State Board (IDMA -GSB) is organising India's largest pharma & healthcare exhibition 'Pharmac India 2009' in Ahmedabad from November 7 to 9. While Pharmexcil is the co-organiser of the event, it is supported by Federation of Pharma Entrepreneurs (FOPE), Sabarkantha District Drug Manufacturers Association, BDMA and Rajasthan Pharmaceutical Manufacturers Association.
Tata Consultancy Services (TCS), the country’s largest software services firm by sales, will reinforce its product-line to boost its offering and ensure growth in the current economic environment.
Sun Pharmaceutical’s US subsidiary, Caraco Pharma, has decided to cut its workforce by more than a half after the recent clampdown by USFDA on the company’s manufacturing facilities had idled most units.
Union government is formulating a policy for traceability in packaging for the pharmaceutical sector. The traceability norms are expected to put an end to the undesirable use of recycled bottles by the pharmaceutical companies.
Vietnamese pharmaceutical products are yet to gain a reputation in Cambodia and domestic companies have to employ specific strategies to tap the significant potential that the neighbouring nation’s market presents, several exporters say.
The domestic pharma industry is going to seek an upward revision in drug prices by submitting a report on the increase in conversion and packaging costs to the Indian drug price regulator National Pharmaceutical Pricing Authority (NPPA).
India’s logistics industry, expected to reach a market size of around $125 billion by next year, is scaling up for the pharmaceutical sector, widely considered as recession-proof.
Contract manufacturing is one of the best options for the global pharma companies to look forward to in the wake of global recession. The attraction for the global companies to choose India as the ideal hub for contract manufacturing is the opportunity of submission of increasing number of drug master files which has grown to almost 46 per cent in 2007 from a mere 14 per cent in 2000.
The government should encourage the development of domestic pharmaceutical industry to provide good quality and cost effective medicines to people.
Pharmaceutical companies have to adopt a target-market and flexible pricing approach to increase their revenue as emerging economies grow, according to a report from financial consulting firm PricewaterhouseCoopers (PwC).
The drug price regulator, National Pharmaceutical Pricing Authority (NPPA), has revised prices of 285 medicines leading to reduction in prices of 263 medicines. Prices of 22 other medicines have been revised upwardly, an NPPA official said.
In its endeavour to help pharma players from other parts of the world to explore Japanese drug market, the second largest in the world, United Business Media, a leading organiser of trade shows and professional shows in Europe, US and Asia, would host its flagship event CPhI Japan at Tokyo Big Sight Exhibition Centre, Tokyo from April 21 to 23, 2009.
Beware the patent cliff!Blockbusters have been driving growth in the pharma sector. But looming patent losses are forcing companies in new directions
Exports of Pakistan’s pharmaceutical products has registered a 10 percent increase during the previous calendar year of 2008 mainly on account of better marketing approach by the local pharmaceutical companies and their sustained efforts to enhance the quality.
A new Pharma Park project promoted by the Gujarat Industry Development Corporation (GIDC) is under way to provide the small scale drug manufacturers some space in the pharmaceutical industry.
Pharmaceutical and biotechnology major Wockhardt has announced the launch of its new insulin (Glaritus), a recombinant long acting human insulin analogue. Wockhardt is the 1st company in the world after the innovator to launch this new insulin (Glaritus) that works slowly for over 24 hours.
The conversion costs, packaging charges and process loss of materials and packaging material costs are likely to be increased to give some relief to the pharma companies as the National Pharmaceutical Pricing Authority (NPPA) has initiated steps to garner inputs from the manufacturers for finalising the norms for the current year.
Taking cognisance of the increase in input cost, the National Pharmaceutical Pricing Authority (NPPA) may allow drug makers to raise their margins in packaging cost of medicines, a government official said.
Due to the tremendous pressure exerted by the developing countries including India and Brazil, the World Health Organisation (WHO) has dropped the controversial resolution on counterfeit drugs.
